Is Copart (CPRT) a risky stock?
As of July 21, 2026, Clavix grades Copart (CPRT) B- for risk, a composite score of 76 out of 100 on an A+ to F scale, which puts CPRT in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind CPRT's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CPRT scores on each, as of July 21, 2026.
What's moving CPRT's risk right now
Company-specific signals Clavix flags behind CPRT's current grade, drawn from recent news and filings as of July 21, 2026.
Director Daniel Englander sold 80,000 shares for about $2.2 million while the stock has dropped roughly 42% over the past year. Big insider sales during a steep decline can shake outside investors' confidence in the company.
The founder has returned to Copart, which one article reads as a sign of trouble rather than a new growth chapter, citing competitive pressure and slowing growth. Until evidence emerges that these issues are being addressed, the stock could stay under pressure.
What a B- grade means
On the Clavix A+ to F scale, CPRT's composite of 76 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CPRT or any security. Grades are risk indicators, not predictions of return. Data may be delayed.